Icon, the Dublin-based clinical trials for pharmaceutical groups globally, has confirmed that revenue accounting issues extended from 2023 and 2024 into the first nine months of last year, after ...

In addition to extreme heat Monday, the first day of classes at the University of Iowa was off to a rocky start as students and faculty experienced glitches in the school resource applications MyUI ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending ...

SAN FRANCISCO, Feb. 13, 2026 /PRNewswire/ -- Investors in ICON plc (NASDAQ: ICLR) saw the price of their shares drop about 49% during trading on February 12, 2026, after the company disclosed its ...